# SiriusPoint Ltd: financial statements, quarterly

SPNT · NYSE · CIK 1576018 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/spnt.md) · [Financials](/companies/spnt/financials.md) · [Filings](/companies/spnt/filings.md) · [Insiders](/companies/spnt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/spnt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [703](/filings/0001576018-24-000054.md) | [646 d](/filings/0001576018-26-000032.md) | [686](/filings/0001576018-25-000019.md) | [743](/filings/0001576018-25-000033.md) | [562](/filings/0001576018-25-000044.md) | [613 d](/filings/0001576018-26-000032.md) | [727](/filings/0001576018-26-000065.md) | [748](/filings/0001576018-26-000085.md) | [756](/filings/0001576018-25-000044.md) | [974 d](/filings/0001576018-26-000032.md) | [775](/filings/0001576018-26-000065.md) | [744](/filings/0001576018-26-000085.md) |
| Interest expense | $m | [19.8](/filings/0001576018-24-000054.md) | [19.8 d](/filings/0001576018-26-000032.md) | [20.5](/filings/0001576018-25-000019.md) | [15.7](/filings/0001576018-25-000033.md) | [13.8](/filings/0001576018-25-000044.md) | [19.6 d](/filings/0001576018-26-000032.md) | [18.1](/filings/0001576018-26-000065.md) | [21.1](/filings/0001576018-26-000085.md) | [21.0](/filings/0001576018-25-000044.md) | [19.5 d](/filings/0001576018-26-000032.md) | [16.8](/filings/0001576018-26-000065.md) | [18.7](/filings/0001576018-26-000085.md) |
| Income tax | $m | [15.3](/filings/0001576018-24-000054.md) | [(102) d](/filings/0001576018-26-000032.md) | [9.7](/filings/0001576018-25-000019.md) | [14.2](/filings/0001576018-25-000033.md) | [2.4](/filings/0001576018-25-000044.md) | [4.4 d](/filings/0001576018-26-000032.md) | [13.3](/filings/0001576018-26-000065.md) | [11.6](/filings/0001576018-26-000085.md) | [20.2](/filings/0001576018-25-000044.md) | [36.1 d](/filings/0001576018-26-000032.md) | [19.2](/filings/0001576018-26-000065.md) | [15.8](/filings/0001576018-26-000085.md) |
| Net income | $m | [61.5](/filings/0001576018-24-000054.md) | [97.5 d](/filings/0001576018-26-000032.md) | [94.8](/filings/0001576018-25-000019.md) | [114](/filings/0001576018-25-000033.md) | [8.5](/filings/0001576018-25-000044.md) | [(17.3) d](/filings/0001576018-26-000032.md) | [61.6](/filings/0001576018-26-000065.md) | [63.2](/filings/0001576018-26-000085.md) | [90.8](/filings/0001576018-25-000044.md) | [244 d](/filings/0001576018-26-000032.md) | [102](/filings/0001576018-26-000065.md) | [68.6](/filings/0001576018-26-000085.md) |
| Diluted EPS | $ per share | [0.32](/filings/0001576018-24-000054.md) | not reported | [0.49](/filings/0001576018-25-000019.md) | [0.57](/filings/0001576018-25-000033.md) | [0.03](/filings/0001576018-25-000044.md) | not reported | [0.49](/filings/0001576018-26-000065.md) | [0.50](/filings/0001576018-26-000085.md) | [0.73](/filings/0001576018-25-000044.md) | not reported | [0.82](/filings/0001576018-26-000065.md) | [0.58](/filings/0001576018-26-000085.md) |
| Basic EPS | $ per share | [0.33](/filings/0001576018-24-000054.md) | not reported | [0.50](/filings/0001576018-25-000019.md) | [0.60](/filings/0001576018-25-000033.md) | [0.03](/filings/0001576018-25-000044.md) | not reported | [0.50](/filings/0001576018-26-000065.md) | [0.51](/filings/0001576018-26-000085.md) | [0.74](/filings/0001576018-25-000044.md) | not reported | [0.85](/filings/0001576018-26-000065.md) | [0.59](/filings/0001576018-26-000085.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0001576018-23-000112.md) | [1.0](/filings/0001576018-25-000010.md) | [0.9](/filings/0001576018-24-000031.md) | [0.6](/filings/0001576018-24-000042.md) | [0.6](/filings/0001576018-24-000054.md) | [0.7](/filings/0001576018-26-000032.md) | [0.7](/filings/0001576018-25-000019.md) | [0.7](/filings/0001576018-25-000033.md) | [0.6](/filings/0001576018-25-000044.md) | [0.7](/filings/0001576018-26-000085.md) | [0.9](/filings/0001576018-26-000065.md) | [0.6](/filings/0001576018-26-000085.md) |
| Total assets | $bn | [12.6](/filings/0001576018-23-000112.md) | [12.9](/filings/0001576018-25-000010.md) | [13.1](/filings/0001576018-24-000031.md) | [12.8](/filings/0001576018-24-000042.md) | [12.7](/filings/0001576018-24-000054.md) | [12.5](/filings/0001576018-26-000032.md) | [12.3](/filings/0001576018-25-000019.md) | [12.4](/filings/0001576018-25-000033.md) | [12.5](/filings/0001576018-25-000044.md) | [12.6](/filings/0001576018-26-000085.md) | [12.5](/filings/0001576018-26-000065.md) | [12.7](/filings/0001576018-26-000085.md) |
| Total liabilities | $bn | [10.3](/filings/0001576018-23-000112.md) | [10.3](/filings/0001576018-25-000010.md) | [10.5](/filings/0001576018-24-000031.md) | [10.1](/filings/0001576018-24-000042.md) | [10.0](/filings/0001576018-24-000054.md) | [10.6](/filings/0001576018-26-000032.md) | [10.3](/filings/0001576018-25-000019.md) | [10.2](/filings/0001576018-25-000033.md) | [10.2](/filings/0001576018-25-000044.md) | [10.1](/filings/0001576018-26-000085.md) | [10.2](/filings/0001576018-26-000065.md) | [10.4](/filings/0001576018-26-000085.md) |
| Long-term debt | $bn | [0.8](/filings/0001576018-23-000112.md) | [0.8](/filings/0001576018-25-000010.md) | [0.8](/filings/0001576018-24-000031.md) | [0.6](/filings/0001576018-24-000042.md) | [0.7](/filings/0001576018-24-000054.md) | [0.6](/filings/0001576018-26-000032.md) | [0.7](/filings/0001576018-25-000019.md) | [0.7](/filings/0001576018-25-000033.md) | [0.7](/filings/0001576018-25-000044.md) | [0.7](/filings/0001576018-26-000085.md) | [0.7](/filings/0001576018-26-000065.md) | [0.7](/filings/0001576018-26-000085.md) |
| Shareholders' equity | $bn | [2.3](/filings/0001576018-23-000112.md) | [2.5](/filings/0001576018-25-000010.md) | [2.6](/filings/0001576018-24-000031.md) | [2.7](/filings/0001576018-24-000042.md) | [2.7](/filings/0001576018-24-000054.md) | [1.9](/filings/0001576018-26-000032.md) | [2.0](/filings/0001576018-25-000019.md) | [2.1](/filings/0001576018-25-000033.md) | [2.2](/filings/0001576018-25-000044.md) | [2.5](/filings/0001576018-26-000085.md) | [2.3](/filings/0001576018-26-000065.md) | [2.3](/filings/0001576018-26-000085.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [162 d](/filings/0001576018-24-000054.md) | [213 d](/filings/0001576018-26-000032.md) | [58.8](/filings/0001576018-25-000019.md) | [(150) d](/filings/0001576018-25-000033.md) | [58.1 d](/filings/0001576018-25-000044.md) | [108 d](/filings/0001576018-26-000032.md) | [(88.9)](/filings/0001576018-26-000065.md) | [62.1 d](/filings/0001576018-26-000085.md) | [156 d](/filings/0001576018-25-000044.md) | [(26.4) d](/filings/0001576018-26-000032.md) | [142](/filings/0001576018-26-000065.md) | [(5.2) d](/filings/0001576018-26-000085.md) |
| Dividends paid | $m | [0.0 d](/filings/0001576018-24-000054.md) | [0.0 d](/filings/0001576018-26-000032.md) | [0.0](/filings/0001576018-25-000019.md) | [0.0 d](/filings/0001576018-25-000033.md) | [0.0 d](/filings/0001576018-25-000044.md) | [0.0 d](/filings/0001576018-26-000032.md) | [0.0](/filings/0001576018-26-000065.md) | [0.0 d](/filings/0001576018-26-000085.md) | [0.0 d](/filings/0001576018-25-000044.md) | [0.0 d](/filings/0001576018-26-000032.md) | [0.0](/filings/0001576018-26-000065.md) | [0.0 d](/filings/0001576018-26-000085.md) |
| Share repurchases | $m | [0.0 d](/filings/0001576018-24-000054.md) | [0.0 d](/filings/0001576018-26-000032.md) | [0.0](/filings/0001576018-25-000019.md) | [0.0 d](/filings/0001576018-25-000033.md) | [130 d](/filings/0001576018-25-000044.md) | [170 d](/filings/0001576018-26-000032.md) | [491](/filings/0001576018-26-000065.md) | [0.0 d](/filings/0001576018-26-000085.md) | [0.0 d](/filings/0001576018-25-000044.md) | [0.0 d](/filings/0001576018-26-000032.md) | [21.9](/filings/0001576018-26-000065.md) | [51.4 d](/filings/0001576018-26-000085.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [160](/filings/0001576018-23-000112.md) | [164](/filings/0001576018-24-000031.md) | [167](/filings/0001576018-24-000042.md) | [169](/filings/0001576018-24-000054.md) | [174](/filings/0001576018-25-000019.md) | [179](/filings/0001576018-25-000033.md) | [173](/filings/0001576018-25-000044.md) | [119](/filings/0001576018-26-000065.md) | [119](/filings/0001576018-26-000085.md) | [119](/filings/0001576018-25-000044.md) | [122](/filings/0001576018-26-000065.md) | [119](/filings/0001576018-26-000085.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 116,165,016 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0001576018-26-000085.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.